CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 27 filers reported holding CARDIOME PHARMA CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $62,000 | -3.1% | 13,800 | -35.5% | 0.00% | – |
| Q1 2017 | $64,000 | -62.6% | 21,379 | -65.6% | 0.00% | – |
| Q4 2016 | $171,000 | -20.5% | 62,067 | -9.5% | 0.00% | – |
| Q3 2016 | $215,000 | +83.8% | 68,581 | +199.5% | 0.00% | – |
| Q2 2016 | $117,000 | +25.8% | 22,900 | +99.1% | 0.00% | – |
| Q4 2015 | $93,000 | -94.8% | 11,500 | -94.5% | 0.00% | -100.0% |
| Q3 2015 | $1,778,000 | +11.3% | 210,620 | +24.1% | 0.00% | – |
| Q2 2015 | $1,597,000 | +71.9% | 169,752 | +69.2% | 0.00% | – |
| Q1 2015 | $929,000 | +29.4% | 100,334 | +29.2% | 0.00% | – |
| Q4 2014 | $718,000 | -9.8% | 77,654 | -12.9% | 0.00% | – |
| Q3 2014 | $796,000 | -57.1% | 89,195 | -62.2% | 0.00% | – |
| Q2 2014 | $1,856,000 | +1.5% | 235,862 | +1.9% | 0.00% | – |
| Q1 2014 | $1,829,000 | +57.3% | 231,352 | +23.9% | 0.00% | – |
| Q4 2013 | $1,163,000 | +280.1% | 186,733 | +115.7% | 0.00% | – |
| Q3 2013 | $306,000 | +646.3% | 86,572 | +308.4% | 0.00% | – |
| Q2 2013 | $41,000 | – | 21,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alistair Capital Management, L.L.C. | 917,400 | $5,715,000 | 2.56% |
| Fortress Investment Group LLC | 2,481,596 | $15,460,000 | 0.24% |
| PERKINS CAPITAL MANAGEMENT INC | 14,000 | $87,000 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,332,260 | $8,386,000 | 0.02% |
| TFS CAPITAL LLC | 26,116 | $163,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 54,815 | $342,000 | 0.01% |
| Renaissance Technologies | 218,913 | $1,364,000 | 0.00% |
| Alberta Investment Management Corp | 19,140 | $128,000 | 0.00% |
| OAK RIDGE INVESTMENTS LLC | 11,055 | $69,000 | 0.00% |
| CLEAR STREET MARKETS LLC | 600 | $4,000 | 0.00% |